nodes	percent_of_prediction	percent_of_DWPC	metapath
Busulfan—Alkylating Activity—Temozolomide—skin cancer	0.453	0.556	CiPCiCtD
Busulfan—Alkylating Activity—Dacarbazine—skin cancer	0.363	0.444	CiPCiCtD
Busulfan—CYP3A4—Imiquimod—skin cancer	0.0201	0.292	CbGbCtD
Busulfan—CYP3A4—Temozolomide—skin cancer	0.0201	0.292	CbGbCtD
Busulfan—CYP3A4—Vismodegib—skin cancer	0.014	0.202	CbGbCtD
Busulfan—CYP3A4—Vemurafenib—skin cancer	0.011	0.16	CbGbCtD
Busulfan—CYP3A4—Docetaxel—skin cancer	0.00378	0.0548	CbGbCtD
Busulfan—MGST2—hair follicle—skin cancer	0.00294	0.114	CbGeAlD
Busulfan—GSTM1—blood vessel—skin cancer	0.00173	0.067	CbGeAlD
Busulfan—GSTM1—neck—skin cancer	0.00124	0.048	CbGeAlD
Busulfan—GSTA1—connective tissue—skin cancer	0.0012	0.0465	CbGeAlD
Busulfan—GSTP1—hair follicle—skin cancer	0.00116	0.0448	CbGeAlD
Busulfan—GSTA1—epithelium—skin cancer	0.00114	0.0441	CbGeAlD
Busulfan—MGST2—female reproductive system—skin cancer	0.000997	0.0385	CbGeAlD
Busulfan—GSTM1—connective tissue—skin cancer	0.000889	0.0344	CbGeAlD
Busulfan—GSTA1—lymphoid tissue—skin cancer	0.000879	0.034	CbGeAlD
Busulfan—GSTA2—connective tissue—skin cancer	0.000867	0.0335	CbGeAlD
Busulfan—GSTA1—female reproductive system—skin cancer	0.000847	0.0328	CbGeAlD
Busulfan—GSTA2—epithelium—skin cancer	0.000823	0.0318	CbGeAlD
Busulfan—GSTM1—skin of body—skin cancer	0.000803	0.031	CbGeAlD
Busulfan—GSTP1—nipple—skin cancer	0.000785	0.0304	CbGeAlD
Busulfan—GSTP1—neck—skin cancer	0.000777	0.03	CbGeAlD
Busulfan—GSTA1—head—skin cancer	0.000708	0.0274	CbGeAlD
Busulfan—GSTM1—lymphoid tissue—skin cancer	0.00065	0.0251	CbGeAlD
Busulfan—GSTA2—lymphoid tissue—skin cancer	0.000634	0.0245	CbGeAlD
Busulfan—GSTM1—female reproductive system—skin cancer	0.000627	0.0242	CbGeAlD
Busulfan—GSTA2—female reproductive system—skin cancer	0.000612	0.0236	CbGeAlD
Busulfan—MGST2—lymph node—skin cancer	0.000583	0.0225	CbGeAlD
Busulfan—GSTP1—connective tissue—skin cancer	0.000557	0.0215	CbGeAlD
Busulfan—GSTP1—epithelium—skin cancer	0.000529	0.0204	CbGeAlD
Busulfan—GSTM1—head—skin cancer	0.000524	0.0203	CbGeAlD
Busulfan—GSTA2—head—skin cancer	0.000511	0.0198	CbGeAlD
Busulfan—GSTP1—skin of body—skin cancer	0.000503	0.0194	CbGeAlD
Busulfan—GSTP1—mammalian vulva—skin cancer	0.000458	0.0177	CbGeAlD
Busulfan—GSTP1—lymphoid tissue—skin cancer	0.000407	0.0157	CbGeAlD
Busulfan—GSTP1—female reproductive system—skin cancer	0.000393	0.0152	CbGeAlD
Busulfan—GSTM1—lymph node—skin cancer	0.000367	0.0142	CbGeAlD
Busulfan—GSTP1—head—skin cancer	0.000328	0.0127	CbGeAlD
Busulfan—GSTP1—lymph node—skin cancer	0.00023	0.00888	CbGeAlD
Busulfan—CYP3A4—female reproductive system—skin cancer	0.00016	0.00619	CbGeAlD
Busulfan—Alopecia—Dactinomycin—skin cancer	8.97e-05	0.00101	CcSEcCtD
Busulfan—Feeling abnormal—Imiquimod—skin cancer	8.97e-05	0.00101	CcSEcCtD
Busulfan—Gastrointestinal pain—Imiquimod—skin cancer	8.9e-05	0.000999	CcSEcCtD
Busulfan—Epistaxis—Fluorouracil—skin cancer	8.89e-05	0.000998	CcSEcCtD
Busulfan—Hyponatraemia—Docetaxel—skin cancer	8.86e-05	0.000995	CcSEcCtD
Busulfan—Sinusitis—Fluorouracil—skin cancer	8.84e-05	0.000992	CcSEcCtD
Busulfan—Erythema—Dactinomycin—skin cancer	8.84e-05	0.000992	CcSEcCtD
Busulfan—Gastrointestinal haemorrhage—Docetaxel—skin cancer	8.83e-05	0.000991	CcSEcCtD
Busulfan—Agranulocytosis—Fluorouracil—skin cancer	8.8e-05	0.000987	CcSEcCtD
Busulfan—Anaemia—Bleomycin—skin cancer	8.76e-05	0.000983	CcSEcCtD
Busulfan—Diarrhoea—Vemurafenib—skin cancer	8.73e-05	0.00098	CcSEcCtD
Busulfan—Erythema multiforme—Temozolomide—skin cancer	8.68e-05	0.000974	CcSEcCtD
Busulfan—Urticaria—Imiquimod—skin cancer	8.65e-05	0.00097	CcSEcCtD
Busulfan—Body temperature increased—Imiquimod—skin cancer	8.61e-05	0.000966	CcSEcCtD
Busulfan—Abdominal pain—Imiquimod—skin cancer	8.61e-05	0.000966	CcSEcCtD
Busulfan—Eye disorder—Temozolomide—skin cancer	8.58e-05	0.000963	CcSEcCtD
Busulfan—Flushing—Temozolomide—skin cancer	8.52e-05	0.000956	CcSEcCtD
Busulfan—Cardiac disorder—Temozolomide—skin cancer	8.52e-05	0.000956	CcSEcCtD
Busulfan—Haemoglobin—Fluorouracil—skin cancer	8.5e-05	0.000954	CcSEcCtD
Busulfan—Leukopenia—Bleomycin—skin cancer	8.48e-05	0.000952	CcSEcCtD
Busulfan—Rhinitis—Fluorouracil—skin cancer	8.48e-05	0.000952	CcSEcCtD
Busulfan—Haemorrhage—Fluorouracil—skin cancer	8.46e-05	0.000949	CcSEcCtD
Busulfan—Dizziness—Vemurafenib—skin cancer	8.44e-05	0.000947	CcSEcCtD
Busulfan—Pharyngitis—Fluorouracil—skin cancer	8.4e-05	0.000942	CcSEcCtD
Busulfan—Angiopathy—Temozolomide—skin cancer	8.33e-05	0.000935	CcSEcCtD
Busulfan—Immune system disorder—Temozolomide—skin cancer	8.29e-05	0.000931	CcSEcCtD
Busulfan—Mediastinal disorder—Temozolomide—skin cancer	8.28e-05	0.000929	CcSEcCtD
Busulfan—Cough—Bleomycin—skin cancer	8.27e-05	0.000928	CcSEcCtD
Busulfan—Chills—Temozolomide—skin cancer	8.24e-05	0.000925	CcSEcCtD
Busulfan—Anaemia—Dactinomycin—skin cancer	8.17e-05	0.000917	CcSEcCtD
Busulfan—Vomiting—Vemurafenib—skin cancer	8.12e-05	0.000911	CcSEcCtD
Busulfan—Alopecia—Temozolomide—skin cancer	8.11e-05	0.000911	CcSEcCtD
Busulfan—Myalgia—Bleomycin—skin cancer	8.07e-05	0.000905	CcSEcCtD
Busulfan—Chest pain—Bleomycin—skin cancer	8.07e-05	0.000905	CcSEcCtD
Busulfan—Rash—Vemurafenib—skin cancer	8.05e-05	0.000903	CcSEcCtD
Busulfan—Mental disorder—Temozolomide—skin cancer	8.04e-05	0.000903	CcSEcCtD
Busulfan—Dermatitis—Vemurafenib—skin cancer	8.04e-05	0.000902	CcSEcCtD
Busulfan—Hypersensitivity—Imiquimod—skin cancer	8.02e-05	0.0009	CcSEcCtD
Busulfan—Headache—Vemurafenib—skin cancer	8e-05	0.000897	CcSEcCtD
Busulfan—Malnutrition—Temozolomide—skin cancer	7.99e-05	0.000897	CcSEcCtD
Busulfan—Erythema—Temozolomide—skin cancer	7.99e-05	0.000897	CcSEcCtD
Busulfan—Aspartate aminotransferase increased—Docetaxel—skin cancer	7.95e-05	0.000892	CcSEcCtD
Busulfan—Leukopenia—Dactinomycin—skin cancer	7.91e-05	0.000888	CcSEcCtD
Busulfan—Asthenia—Imiquimod—skin cancer	7.81e-05	0.000877	CcSEcCtD
Busulfan—Confusional state—Bleomycin—skin cancer	7.8e-05	0.000875	CcSEcCtD
Busulfan—Alanine aminotransferase increased—Docetaxel—skin cancer	7.79e-05	0.000874	CcSEcCtD
Busulfan—Oedema—Bleomycin—skin cancer	7.73e-05	0.000868	CcSEcCtD
Busulfan—Back pain—Temozolomide—skin cancer	7.73e-05	0.000868	CcSEcCtD
Busulfan—Pruritus—Imiquimod—skin cancer	7.7e-05	0.000864	CcSEcCtD
Busulfan—Infection—Bleomycin—skin cancer	7.68e-05	0.000862	CcSEcCtD
Busulfan—Nausea—Vemurafenib—skin cancer	7.58e-05	0.000851	CcSEcCtD
Busulfan—Thrombocytopenia—Bleomycin—skin cancer	7.57e-05	0.00085	CcSEcCtD
Busulfan—Arrhythmia—Fluorouracil—skin cancer	7.56e-05	0.000848	CcSEcCtD
Busulfan—Myalgia—Dactinomycin—skin cancer	7.52e-05	0.000844	CcSEcCtD
Busulfan—Alopecia—Fluorouracil—skin cancer	7.48e-05	0.000839	CcSEcCtD
Busulfan—Diarrhoea—Imiquimod—skin cancer	7.45e-05	0.000836	CcSEcCtD
Busulfan—Anaemia—Temozolomide—skin cancer	7.39e-05	0.000829	CcSEcCtD
Busulfan—Anorexia—Bleomycin—skin cancer	7.37e-05	0.000827	CcSEcCtD
Busulfan—Erythema—Fluorouracil—skin cancer	7.37e-05	0.000826	CcSEcCtD
Busulfan—Agitation—Temozolomide—skin cancer	7.35e-05	0.000824	CcSEcCtD
Busulfan—Pancytopenia—Docetaxel—skin cancer	7.25e-05	0.000813	CcSEcCtD
Busulfan—Hypotension—Bleomycin—skin cancer	7.23e-05	0.000811	CcSEcCtD
Busulfan—Oedema—Dactinomycin—skin cancer	7.21e-05	0.000809	CcSEcCtD
Busulfan—Dizziness—Imiquimod—skin cancer	7.2e-05	0.000808	CcSEcCtD
Busulfan—Infection—Dactinomycin—skin cancer	7.17e-05	0.000804	CcSEcCtD
Busulfan—Leukopenia—Temozolomide—skin cancer	7.16e-05	0.000803	CcSEcCtD
Busulfan—Neutropenia—Docetaxel—skin cancer	7.13e-05	0.000801	CcSEcCtD
Busulfan—Thrombocytopenia—Dactinomycin—skin cancer	7.06e-05	0.000793	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Bleomycin—skin cancer	7.05e-05	0.000791	CcSEcCtD
Busulfan—Cough—Temozolomide—skin cancer	6.98e-05	0.000783	CcSEcCtD
Busulfan—Weight increased—Docetaxel—skin cancer	6.94e-05	0.000779	CcSEcCtD
Busulfan—Convulsion—Temozolomide—skin cancer	6.93e-05	0.000777	CcSEcCtD
Busulfan—Vomiting—Imiquimod—skin cancer	6.92e-05	0.000777	CcSEcCtD
Busulfan—Weight decreased—Docetaxel—skin cancer	6.9e-05	0.000775	CcSEcCtD
Busulfan—Hypertension—Temozolomide—skin cancer	6.9e-05	0.000774	CcSEcCtD
Busulfan—Dyspnoea—Bleomycin—skin cancer	6.9e-05	0.000774	CcSEcCtD
Busulfan—Anorexia—Dactinomycin—skin cancer	6.88e-05	0.000772	CcSEcCtD
Busulfan—Rash—Imiquimod—skin cancer	6.86e-05	0.00077	CcSEcCtD
Busulfan—Dermatitis—Imiquimod—skin cancer	6.86e-05	0.00077	CcSEcCtD
Busulfan—Pneumonia—Docetaxel—skin cancer	6.84e-05	0.000768	CcSEcCtD
Busulfan—Headache—Imiquimod—skin cancer	6.82e-05	0.000765	CcSEcCtD
Busulfan—Anaemia—Fluorouracil—skin cancer	6.81e-05	0.000764	CcSEcCtD
Busulfan—Myalgia—Temozolomide—skin cancer	6.81e-05	0.000764	CcSEcCtD
Busulfan—Arthralgia—Temozolomide—skin cancer	6.81e-05	0.000764	CcSEcCtD
Busulfan—Infestation—Docetaxel—skin cancer	6.8e-05	0.000763	CcSEcCtD
Busulfan—Infestation NOS—Docetaxel—skin cancer	6.8e-05	0.000763	CcSEcCtD
Busulfan—Anxiety—Temozolomide—skin cancer	6.78e-05	0.000761	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	6.76e-05	0.000758	CcSEcCtD
Busulfan—Decreased appetite—Bleomycin—skin cancer	6.72e-05	0.000754	CcSEcCtD
Busulfan—Renal failure—Docetaxel—skin cancer	6.69e-05	0.00075	CcSEcCtD
Busulfan—Dry mouth—Temozolomide—skin cancer	6.66e-05	0.000747	CcSEcCtD
Busulfan—Jaundice—Docetaxel—skin cancer	6.63e-05	0.000744	CcSEcCtD
Busulfan—Stomatitis—Docetaxel—skin cancer	6.63e-05	0.000744	CcSEcCtD
Busulfan—Pain—Bleomycin—skin cancer	6.61e-05	0.000742	CcSEcCtD
Busulfan—Leukopenia—Fluorouracil—skin cancer	6.59e-05	0.00074	CcSEcCtD
Busulfan—Confusional state—Temozolomide—skin cancer	6.58e-05	0.000738	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Dactinomycin—skin cancer	6.57e-05	0.000737	CcSEcCtD
Busulfan—Oedema—Temozolomide—skin cancer	6.52e-05	0.000732	CcSEcCtD
Busulfan—Infection—Temozolomide—skin cancer	6.48e-05	0.000727	CcSEcCtD
Busulfan—Nausea—Imiquimod—skin cancer	6.47e-05	0.000726	CcSEcCtD
Busulfan—Hepatobiliary disease—Docetaxel—skin cancer	6.43e-05	0.000722	CcSEcCtD
Busulfan—Epistaxis—Docetaxel—skin cancer	6.42e-05	0.00072	CcSEcCtD
Busulfan—Nervous system disorder—Temozolomide—skin cancer	6.4e-05	0.000718	CcSEcCtD
Busulfan—Thrombocytopenia—Temozolomide—skin cancer	6.39e-05	0.000717	CcSEcCtD
Busulfan—Convulsion—Fluorouracil—skin cancer	6.38e-05	0.000716	CcSEcCtD
Busulfan—Feeling abnormal—Bleomycin—skin cancer	6.37e-05	0.000715	CcSEcCtD
Busulfan—Agranulocytosis—Docetaxel—skin cancer	6.35e-05	0.000712	CcSEcCtD
Busulfan—Skin disorder—Temozolomide—skin cancer	6.34e-05	0.000711	CcSEcCtD
Busulfan—Myalgia—Fluorouracil—skin cancer	6.27e-05	0.000704	CcSEcCtD
Busulfan—Chest pain—Fluorouracil—skin cancer	6.27e-05	0.000704	CcSEcCtD
Busulfan—Decreased appetite—Dactinomycin—skin cancer	6.27e-05	0.000704	CcSEcCtD
Busulfan—Fatigue—Dactinomycin—skin cancer	6.22e-05	0.000698	CcSEcCtD
Busulfan—Anorexia—Temozolomide—skin cancer	6.22e-05	0.000698	CcSEcCtD
Busulfan—Pain—Dactinomycin—skin cancer	6.17e-05	0.000692	CcSEcCtD
Busulfan—Urticaria—Bleomycin—skin cancer	6.14e-05	0.000689	CcSEcCtD
Busulfan—Haemoglobin—Docetaxel—skin cancer	6.14e-05	0.000689	CcSEcCtD
Busulfan—Rhinitis—Docetaxel—skin cancer	6.12e-05	0.000687	CcSEcCtD
Busulfan—Body temperature increased—Bleomycin—skin cancer	6.11e-05	0.000686	CcSEcCtD
Busulfan—Haemorrhage—Docetaxel—skin cancer	6.11e-05	0.000685	CcSEcCtD
Busulfan—Confusional state—Fluorouracil—skin cancer	6.06e-05	0.00068	CcSEcCtD
Busulfan—Pharyngitis—Docetaxel—skin cancer	6.06e-05	0.00068	CcSEcCtD
Busulfan—Urinary tract disorder—Docetaxel—skin cancer	6.03e-05	0.000677	CcSEcCtD
Busulfan—Oedema—Fluorouracil—skin cancer	6.01e-05	0.000675	CcSEcCtD
Busulfan—Connective tissue disorder—Docetaxel—skin cancer	6e-05	0.000673	CcSEcCtD
Busulfan—Urethral disorder—Docetaxel—skin cancer	5.99e-05	0.000672	CcSEcCtD
Busulfan—Infection—Fluorouracil—skin cancer	5.97e-05	0.00067	CcSEcCtD
Busulfan—Feeling abnormal—Dactinomycin—skin cancer	5.94e-05	0.000667	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Temozolomide—skin cancer	5.94e-05	0.000667	CcSEcCtD
Busulfan—Insomnia—Temozolomide—skin cancer	5.9e-05	0.000662	CcSEcCtD
Busulfan—Gastrointestinal pain—Dactinomycin—skin cancer	5.9e-05	0.000662	CcSEcCtD
Busulfan—Nervous system disorder—Fluorouracil—skin cancer	5.89e-05	0.000662	CcSEcCtD
Busulfan—Thrombocytopenia—Fluorouracil—skin cancer	5.89e-05	0.00066	CcSEcCtD
Busulfan—Tachycardia—Fluorouracil—skin cancer	5.87e-05	0.000658	CcSEcCtD
Busulfan—Dyspnoea—Temozolomide—skin cancer	5.82e-05	0.000653	CcSEcCtD
Busulfan—Somnolence—Temozolomide—skin cancer	5.8e-05	0.000651	CcSEcCtD
Busulfan—Erythema multiforme—Docetaxel—skin cancer	5.77e-05	0.000648	CcSEcCtD
Busulfan—Dyspepsia—Temozolomide—skin cancer	5.74e-05	0.000644	CcSEcCtD
Busulfan—Anorexia—Fluorouracil—skin cancer	5.73e-05	0.000643	CcSEcCtD
Busulfan—Eye disorder—Docetaxel—skin cancer	5.71e-05	0.00064	CcSEcCtD
Busulfan—Abdominal pain—Dactinomycin—skin cancer	5.7e-05	0.00064	CcSEcCtD
Busulfan—Body temperature increased—Dactinomycin—skin cancer	5.7e-05	0.00064	CcSEcCtD
Busulfan—Hypersensitivity—Bleomycin—skin cancer	5.7e-05	0.000639	CcSEcCtD
Busulfan—Decreased appetite—Temozolomide—skin cancer	5.67e-05	0.000636	CcSEcCtD
Busulfan—Cardiac disorder—Docetaxel—skin cancer	5.67e-05	0.000636	CcSEcCtD
Busulfan—Flushing—Docetaxel—skin cancer	5.67e-05	0.000636	CcSEcCtD
Busulfan—Gastrointestinal disorder—Temozolomide—skin cancer	5.63e-05	0.000632	CcSEcCtD
Busulfan—Fatigue—Temozolomide—skin cancer	5.62e-05	0.000631	CcSEcCtD
Busulfan—Hypotension—Fluorouracil—skin cancer	5.62e-05	0.00063	CcSEcCtD
Busulfan—Constipation—Temozolomide—skin cancer	5.58e-05	0.000626	CcSEcCtD
Busulfan—Pain—Temozolomide—skin cancer	5.58e-05	0.000626	CcSEcCtD
Busulfan—Asthenia—Bleomycin—skin cancer	5.55e-05	0.000623	CcSEcCtD
Busulfan—Angiopathy—Docetaxel—skin cancer	5.54e-05	0.000622	CcSEcCtD
Busulfan—Immune system disorder—Docetaxel—skin cancer	5.52e-05	0.000619	CcSEcCtD
Busulfan—Mediastinal disorder—Docetaxel—skin cancer	5.5e-05	0.000618	CcSEcCtD
Busulfan—Chills—Docetaxel—skin cancer	5.48e-05	0.000615	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Fluorouracil—skin cancer	5.48e-05	0.000615	CcSEcCtD
Busulfan—Pruritus—Bleomycin—skin cancer	5.47e-05	0.000614	CcSEcCtD
Busulfan—Arrhythmia—Docetaxel—skin cancer	5.46e-05	0.000612	CcSEcCtD
Busulfan—Insomnia—Fluorouracil—skin cancer	5.44e-05	0.00061	CcSEcCtD
Busulfan—Alopecia—Docetaxel—skin cancer	5.4e-05	0.000606	CcSEcCtD
Busulfan—Feeling abnormal—Temozolomide—skin cancer	5.38e-05	0.000603	CcSEcCtD
Busulfan—Dyspnoea—Fluorouracil—skin cancer	5.36e-05	0.000601	CcSEcCtD
Busulfan—Mental disorder—Docetaxel—skin cancer	5.35e-05	0.0006	CcSEcCtD
Busulfan—Somnolence—Fluorouracil—skin cancer	5.34e-05	0.0006	CcSEcCtD
Busulfan—Gastrointestinal pain—Temozolomide—skin cancer	5.33e-05	0.000599	CcSEcCtD
Busulfan—Erythema—Docetaxel—skin cancer	5.32e-05	0.000597	CcSEcCtD
Busulfan—Malnutrition—Docetaxel—skin cancer	5.32e-05	0.000597	CcSEcCtD
Busulfan—Hypersensitivity—Dactinomycin—skin cancer	5.31e-05	0.000596	CcSEcCtD
Busulfan—Dyspepsia—Fluorouracil—skin cancer	5.29e-05	0.000594	CcSEcCtD
Busulfan—Decreased appetite—Fluorouracil—skin cancer	5.23e-05	0.000586	CcSEcCtD
Busulfan—Gastrointestinal disorder—Fluorouracil—skin cancer	5.19e-05	0.000582	CcSEcCtD
Busulfan—Urticaria—Temozolomide—skin cancer	5.18e-05	0.000582	CcSEcCtD
Busulfan—Asthenia—Dactinomycin—skin cancer	5.18e-05	0.000581	CcSEcCtD
Busulfan—Abdominal pain—Temozolomide—skin cancer	5.16e-05	0.000579	CcSEcCtD
Busulfan—Body temperature increased—Temozolomide—skin cancer	5.16e-05	0.000579	CcSEcCtD
Busulfan—Back pain—Docetaxel—skin cancer	5.14e-05	0.000577	CcSEcCtD
Busulfan—Pain—Fluorouracil—skin cancer	5.14e-05	0.000577	CcSEcCtD
Busulfan—Feeling abnormal—Fluorouracil—skin cancer	4.95e-05	0.000556	CcSEcCtD
Busulfan—Diarrhoea—Dactinomycin—skin cancer	4.94e-05	0.000554	CcSEcCtD
Busulfan—Vomiting—Bleomycin—skin cancer	4.92e-05	0.000552	CcSEcCtD
Busulfan—Anaemia—Docetaxel—skin cancer	4.91e-05	0.000551	CcSEcCtD
Busulfan—Rash—Bleomycin—skin cancer	4.88e-05	0.000547	CcSEcCtD
Busulfan—Dermatitis—Bleomycin—skin cancer	4.87e-05	0.000547	CcSEcCtD
Busulfan—Hypersensitivity—Temozolomide—skin cancer	4.81e-05	0.000539	CcSEcCtD
Busulfan—Urticaria—Fluorouracil—skin cancer	4.78e-05	0.000536	CcSEcCtD
Busulfan—Leukopenia—Docetaxel—skin cancer	4.76e-05	0.000534	CcSEcCtD
Busulfan—Body temperature increased—Fluorouracil—skin cancer	4.75e-05	0.000533	CcSEcCtD
Busulfan—Asthenia—Temozolomide—skin cancer	4.68e-05	0.000525	CcSEcCtD
Busulfan—Cough—Docetaxel—skin cancer	4.64e-05	0.000521	CcSEcCtD
Busulfan—Pruritus—Temozolomide—skin cancer	4.62e-05	0.000518	CcSEcCtD
Busulfan—Convulsion—Docetaxel—skin cancer	4.61e-05	0.000517	CcSEcCtD
Busulfan—Nausea—Bleomycin—skin cancer	4.59e-05	0.000516	CcSEcCtD
Busulfan—Hypertension—Docetaxel—skin cancer	4.59e-05	0.000515	CcSEcCtD
Busulfan—Vomiting—Dactinomycin—skin cancer	4.59e-05	0.000515	CcSEcCtD
Busulfan—Rash—Dactinomycin—skin cancer	4.55e-05	0.00051	CcSEcCtD
Busulfan—Chest pain—Docetaxel—skin cancer	4.53e-05	0.000508	CcSEcCtD
Busulfan—Myalgia—Docetaxel—skin cancer	4.53e-05	0.000508	CcSEcCtD
Busulfan—Arthralgia—Docetaxel—skin cancer	4.53e-05	0.000508	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	4.49e-05	0.000504	CcSEcCtD
Busulfan—Diarrhoea—Temozolomide—skin cancer	4.46e-05	0.000501	CcSEcCtD
Busulfan—Hypersensitivity—Fluorouracil—skin cancer	4.43e-05	0.000497	CcSEcCtD
Busulfan—Dry mouth—Docetaxel—skin cancer	4.43e-05	0.000497	CcSEcCtD
Busulfan—Confusional state—Docetaxel—skin cancer	4.37e-05	0.000491	CcSEcCtD
Busulfan—Oedema—Docetaxel—skin cancer	4.34e-05	0.000487	CcSEcCtD
Busulfan—Dizziness—Temozolomide—skin cancer	4.31e-05	0.000484	CcSEcCtD
Busulfan—Infection—Docetaxel—skin cancer	4.31e-05	0.000484	CcSEcCtD
Busulfan—Nausea—Dactinomycin—skin cancer	4.28e-05	0.000481	CcSEcCtD
Busulfan—Nervous system disorder—Docetaxel—skin cancer	4.25e-05	0.000477	CcSEcCtD
Busulfan—Pruritus—Fluorouracil—skin cancer	4.25e-05	0.000477	CcSEcCtD
Busulfan—Thrombocytopenia—Docetaxel—skin cancer	4.25e-05	0.000477	CcSEcCtD
Busulfan—Tachycardia—Docetaxel—skin cancer	4.23e-05	0.000475	CcSEcCtD
Busulfan—Skin disorder—Docetaxel—skin cancer	4.21e-05	0.000473	CcSEcCtD
Busulfan—Vomiting—Temozolomide—skin cancer	4.15e-05	0.000465	CcSEcCtD
Busulfan—Anorexia—Docetaxel—skin cancer	4.14e-05	0.000464	CcSEcCtD
Busulfan—Rash—Temozolomide—skin cancer	4.11e-05	0.000462	CcSEcCtD
Busulfan—Diarrhoea—Fluorouracil—skin cancer	4.11e-05	0.000462	CcSEcCtD
Busulfan—Dermatitis—Temozolomide—skin cancer	4.11e-05	0.000461	CcSEcCtD
Busulfan—Headache—Temozolomide—skin cancer	4.09e-05	0.000459	CcSEcCtD
Busulfan—Hypotension—Docetaxel—skin cancer	4.05e-05	0.000455	CcSEcCtD
Busulfan—Dizziness—Fluorouracil—skin cancer	3.97e-05	0.000446	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Docetaxel—skin cancer	3.95e-05	0.000444	CcSEcCtD
Busulfan—Insomnia—Docetaxel—skin cancer	3.92e-05	0.00044	CcSEcCtD
Busulfan—Nausea—Temozolomide—skin cancer	3.88e-05	0.000435	CcSEcCtD
Busulfan—Dyspnoea—Docetaxel—skin cancer	3.87e-05	0.000434	CcSEcCtD
Busulfan—Somnolence—Docetaxel—skin cancer	3.86e-05	0.000433	CcSEcCtD
Busulfan—Vomiting—Fluorouracil—skin cancer	3.82e-05	0.000429	CcSEcCtD
Busulfan—Dyspepsia—Docetaxel—skin cancer	3.82e-05	0.000429	CcSEcCtD
Busulfan—Rash—Fluorouracil—skin cancer	3.79e-05	0.000425	CcSEcCtD
Busulfan—Dermatitis—Fluorouracil—skin cancer	3.79e-05	0.000425	CcSEcCtD
Busulfan—Decreased appetite—Docetaxel—skin cancer	3.77e-05	0.000423	CcSEcCtD
Busulfan—Headache—Fluorouracil—skin cancer	3.77e-05	0.000423	CcSEcCtD
Busulfan—Gastrointestinal disorder—Docetaxel—skin cancer	3.75e-05	0.00042	CcSEcCtD
Busulfan—Fatigue—Docetaxel—skin cancer	3.74e-05	0.00042	CcSEcCtD
Busulfan—Pain—Docetaxel—skin cancer	3.71e-05	0.000416	CcSEcCtD
Busulfan—Constipation—Docetaxel—skin cancer	3.71e-05	0.000416	CcSEcCtD
Busulfan—Feeling abnormal—Docetaxel—skin cancer	3.58e-05	0.000401	CcSEcCtD
Busulfan—Nausea—Fluorouracil—skin cancer	3.57e-05	0.000401	CcSEcCtD
Busulfan—Gastrointestinal pain—Docetaxel—skin cancer	3.55e-05	0.000398	CcSEcCtD
Busulfan—Body temperature increased—Docetaxel—skin cancer	3.43e-05	0.000385	CcSEcCtD
Busulfan—Abdominal pain—Docetaxel—skin cancer	3.43e-05	0.000385	CcSEcCtD
Busulfan—Hypersensitivity—Docetaxel—skin cancer	3.2e-05	0.000359	CcSEcCtD
Busulfan—Asthenia—Docetaxel—skin cancer	3.11e-05	0.000349	CcSEcCtD
Busulfan—Pruritus—Docetaxel—skin cancer	3.07e-05	0.000344	CcSEcCtD
Busulfan—Diarrhoea—Docetaxel—skin cancer	2.97e-05	0.000333	CcSEcCtD
Busulfan—Dizziness—Docetaxel—skin cancer	2.87e-05	0.000322	CcSEcCtD
Busulfan—Vomiting—Docetaxel—skin cancer	2.76e-05	0.00031	CcSEcCtD
Busulfan—Rash—Docetaxel—skin cancer	2.74e-05	0.000307	CcSEcCtD
Busulfan—Dermatitis—Docetaxel—skin cancer	2.73e-05	0.000307	CcSEcCtD
Busulfan—Headache—Docetaxel—skin cancer	2.72e-05	0.000305	CcSEcCtD
Busulfan—Nausea—Docetaxel—skin cancer	2.58e-05	0.000289	CcSEcCtD
